
Why SPARK Microgravity Is Taking Cancer Research to Space
How removing gravity reveals new insights in cancer research.

How removing gravity reveals new insights in cancer research.

Cancer’s challenge and why SPARK is researching it in space?

How microgravity enables better drug design and novel formulations.

SPARK Microgravity's co-founders share their space research mission during an interview at Barcelona Deep Tech Week 2025.

Why 2D and animal models fail and how microgravity bridges translation.

How microgravity enables better drug design and novel therapeutic formulations.

A beginner-friendly guide to understanding how SPARK Microgravity fits into the future of space.

SPARK’s presence at Frontiers Science House reflects a broader momentum around the company as it continues to develop its orbital oncology platform.

Why microgravity transforms biomedical models for personalized medicine breakthroughs.

How microgravity reveals truer tumor behavior than traditional models.

Unlocking Cancer’s Secrets in Microgravity

SPARK Microgravity’s leadership engaged with partners including Atmos Space Cargo, Space Cargo Unlimited, and Merck Sharp & Dohme (MSD)

A data-driven look at the market for orbital oncology research.

Meet the startup who won #1 EU Deep Tech Award 2025

Real case studies prove ROI of microgravity-enabled pharma innovation.

How cancer's behavior in space reveals new therapeutic targets.

Why space research is essential, not obsolete, for modern oncology.

Solving "Undruggable" Targets with Perfect Crystals

SPARK Microgravity Brings Orbital Oncology Vision to ORBIT FOR LIFE Roundtable at Roche Diagnostics

The clear ROI of orbital labs for oncology R&D.

Allison Bajet, joined an exceptional group of internationally recognized space leaders at Frontiers Science House in Davos for the session “The Space Technology Revolution".

Two female founders are pioneering the next frontier in oncology.

Step-by-step guide to launching your first microgravity research mission.

SPARK Microgravity has successfully completed its integration campaign with Swedish Space Corporation (SSC).

SPARK Microgravity GmbH has clinched the top honor at the Barcelona Deep Tech Summit 2025, taking home the #1 EU Deep Tech Champion Award.

SPARK Microgravity announces plans for Europe’s first commercial cancer lab in space at Frontiers Science House in Davos

Solving "Undruggable" Targets with Perfect Crystals

Unlocking Cancer’s Secrets in Microgravity

Cancer’s challenge and why SPARK is researching it in space?

The clear ROI of orbital labs for oncology R&D.

How microgravity enables better drug design and novel therapeutic formulations.

How removing gravity reveals new insights in cancer research.

Two female founders are pioneering the next frontier in oncology.

A data-driven look at the market for orbital oncology research.

A beginner-friendly guide to understanding how SPARK Microgravity fits into the future of space.

Why 2D and animal models fail and how microgravity bridges translation.

How microgravity reveals truer tumor behavior than traditional models.

Step-by-step guide to launching your first microgravity research mission.

Real case studies prove ROI of microgravity-enabled pharma innovation.

How cancer's behavior in space reveals new therapeutic targets.

How microgravity enables better drug design and novel formulations.

Why space research is essential, not obsolete, for modern oncology.

Why microgravity transforms biomedical models for personalized medicine breakthroughs.